Celltrion “Crown killing treatment in 5 days, coming out at the end of the year”



[ad_1]

Celltrion Corona 19 Antibody Treatment Clinical Substance [사진 셀트리온 제공]

Celltrion Corona 19 Antibody Treatment Clinical Substance [사진 셀트리온 제공]

Seo Jeong-jin, president of Celltrion, which is developing a treatment for the new coronavirus infection (Corona 19), said: “Antibody treatments will be available by the end of the year.”

On the 11th, in an interview with ‘the attention of Kim Jong-bae’, President Seo explained: “To end the coronavirus, a vaccine and a treatment must be present together.”

President Seo said, “We developed the Celltrion (CT-P59) antibody treatment, completed phase 1 and are currently in phase 2 and phase 3,” said President Seo. “We plan to apply for conditional approval with the Korean Food and Drug Administration in the middle of the month.”

Regarding the possibility of mass production early next year, he said: “We are cooperating with the Korea Disease Control Agency, the Health Research Institute and the Ministry of Food and Drug Safety.

President Seo said, “In Korea, there are not that many patients, so I think it is enough to have 100,000 people. It is destroyed, ”he added.

Celltrion President Seo Jeong-jin .. Reporter Oh Jong-taek

Celltrion President Seo Jeong-jin .. Reporter Oh Jong-taek

President Seo explained the reason why the virus must be eliminated within 4-5 days after the diagnosis of Corona 19, “because it is necessary to eliminate the possibility of it developing seriously or becoming a patient with organ damage” .

President Seo said, “The virus has the highest spread from two days before symptoms start to a week after, and is toxic and organ-damaging. It is a problem to convert, “he said.

He stressed that “the special drug that treats organ damage does not exist today and is difficult to remove in the future,” he said. “The most important thing is to diagnose and treat it early.”

Chairman Seo said, “Celltrion’s production capacity is 7% worldwide, and if it produces as much as possible, 1.5-2 million people can be produced,” and said, “It is difficult to produce more than 20 million drugs even if production from all other countries is combined. ”

Chairman Seo said: “If we produce 1.5 million or 2 million people, 100,000 people will be enough for domestic use, so we will provide the rest to the desired country,” he said. “I will try to make it cheaper than the competition.”

Reporter Lee Ji-young [email protected]




[ad_2]